1. Home
  2. MOGU vs KTTA Comparison

MOGU vs KTTA Comparison

Compare MOGU & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MOGU Inc.

MOGU

MOGU Inc.

HOLD

Current Price

$1.90

Market Cap

15.3M

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.40

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGU
KTTA
Founded
2011
2020
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3M
15.6M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
MOGU
KTTA
Price
$1.90
$0.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.9K
★ 147.6K
Earning Date
06-22-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 77.07
EPS
★ N/A
N/A
Revenue
N/A
★ $486,559.00
Revenue This Year
$5,662.49
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.81
★ N/A
Revenue Growth
N/A
★ 3130.37
52 Week Low
$1.27
$0.28
52 Week High
$3.11
$2.06

Technical Indicators

Market Signals
Indicator
MOGU
KTTA
Relative Strength Index (RSI) 38.57 38.22
Support Level $1.27 N/A
Resistance Level $2.10 $0.52
Average True Range (ATR) 0.23 0.04
MACD -0.02 0.00
Stochastic Oscillator 4.92 32.41

Price Performance

Historical Comparison
MOGU
KTTA

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: